Sign in
Qualitative and Quantitative Evaluation of Diabetic Choroidopathy Using Ultra-Widefield Indocyanine Green Angiography (UWF ICGA)
Young Hee Yoon, MD, PhD
Annual Meeting Talks
2021
Progression of diabetic retinopathy in patients treated with 0.2 μg/day
Raymond Iezzi, MD, MS
Updates from the Field
2017
Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies
David M. Brown, MD
Category: Diabetic Retinopathy